Health and Social Care Information Centre. Quarterly Prescription Cost Analysis, England (UK Government Statistical Service, London, 2013).
Prefontaine, E., Sutherland, L.R., Macdonald, J.K. & Cepoiu, M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 1, CD000067 (2009).
Timmer, A., MacDonald, J.W., Tsoulis, D.J. & Macdonald, J.K. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst. Rev. 9, CD000478 (2012).
Cosnes, J. et al. Early administration of azathioprine vs conventional management of Crohn's disease: a randomized controlled trial. Gastroenterology 145, 758–765 (2013).
Chaparro, M. et al. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm. Bowel Dis. 19, 1404–1410 (2013).
Gearry, R.B., Barclay, M.L., Burt, M.J., Collett, J.A. & Chapman, B.A. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiol. Drug Saf. 13, 563–567 (2004).
Daly, A.K. et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat. Genet. 41, 816–819 (2009).
Mallal, S. et al. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568–579 (2008).
Gallagher, R.M. et al. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS ONE 6, e28096 (2011).
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
Barrett, J.C. et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat. Genet. 41, 1330–1334 (2009).
1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G.R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012).
Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).
Ahmad, T. et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122, 854–866 (2002).
Tilney, N.L., Collins, J.J. & Wilson, R.E. Hemorrhagic pancreatitis. A fatal complication of renal transplantation. N. Engl. J. Med. 274, 1051–1057 (1966).
Nogueira, J.R. & Freedman, M.A. Acute pancreatitis as a complication of Imuran therapy in regional enteritis. Gastroenterology 62, 1040–1041 (1972).
Marinaki, A.M. et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 14, 181–187 (2004).
Illing, P.T., Vivian, J.P., Purcell, A.W., Rossjohn, J. & McCluskey, J. Human leukocyte antigen–associated drug hypersensitivity. Curr. Opin. Immunol. 25, 81–89 (2013).
Kindmark, A. et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J. 8, 186–195 (2008).
Spraggs, C.F. et al. HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J. Clin. Oncol. 29, 667–673 (2011).
Illing, P.T. et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486, 554–558 (2012).
Badalov, N. et al. Drug-induced acute pancreatitis: an evidence-based review. Clin. Gastroenterol. Hepatol. 5, 648–661 (2007).
Grant, R.L. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. Br. Med. J. 348, f7450 (2014).
Oliphant, A., Barker, D.L., Stuelpnagel, J.R. & Chee, M.S. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques (suppl.), 56–58 (2002).
Goldstein, J.I. et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics 28, 2543–2545 (2012).
Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955–962 (2008).
Anderson, C.A. et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43, 246–252 (2011).
Yang, J., Lee, S.H., Goddard, M.E. & Visscher, P.M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867–2873 (2010).
Sebastiani, P. et al. Retraction. Science 333, 404 (2011).
Li, Y., Willer, C.J., Ding, J., Scheet, P. & Abecasis, G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Scally, S.W. et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210, 2569–2582 (2013).
Morris, G.M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009).
Trott, O. & Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).